BRCA1 and breast cancer: Similarly, the combination of BKM120 and olaparib dramatically extended the doubling time of tumors in an MMTV-Cre: Brca1(f/f): Trp53 (+/−) breast cancer mouse model (Juvekar et al., 2012).